Literature DB >> 9545355

Absence of soluble leptin receptor in plasma from dbPas/dbPas and other db/db mice.

C Li1, E Ioffe, N Fidahusein, E Connolly, J M Friedman.   

Abstract

The leptin receptor (Ob-R) is alternatively spliced into at least five different RNAs designated Ob-R(a-e). Ob-R(a-d) predict receptors with a single transmembrane domain, and Ob-Re predicts a secreted form of the receptor. The presence of an approximately 120-kDa soluble leptin receptor in mouse plasma was confirmed by precipitation with leptin-Sepharose beads followed by immunobloting with anti-leptin receptor antibodies. The soluble leptin receptor is larger than that predicted by the primary sequence. Deglycosylation of the receptor with peptide N:glycosidase F results in a decrease in molecular mass to a size consistent with that of the primary sequence. The secreted receptor was present in plasma from wild type mice but was truncated in plasma from db3J/db3J and absent in dbPas/dbPas plasma. Although db3J/db3J mice are known to have a frameshift mutation at amino acid 625, the basis for the mutation in dbPas/dbPas mice was not known. Further studies indicated that dbPas/dbPas mice carry a duplication of exons 4 and 5 of Ob-R. This mutation introduces a premature stop codon into the protein at amino acid 281. The absence of Ob-R in db3J/db3J and dbPas/dbPas mice confirm the identify of the 120-kDa plasma protein as Ob-Re.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9545355     DOI: 10.1074/jbc.273.16.10078

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  A susceptibility gene for kidney disease in an obese mouse model of type II diabetes maps to chromosome 8.

Authors:  Streamson Chua; Yifu Li; Shun Mei Liu; Ruijie Liu; Ka Tak Chan; Jeremiah Martino; Zongyu Zheng; Katalin Susztak; Vivette D D'Agati; Ali G Gharavi
Journal:  Kidney Int       Date:  2010-06-02       Impact factor: 10.612

2.  The soluble leptin receptor neutralizes leptin-mediated STAT3 signalling and anorexic responses in vivo.

Authors:  Jiejin Zhang; Philip J Scarpace
Journal:  Br J Pharmacol       Date:  2009-05-06       Impact factor: 8.739

3.  Reanalysis of parabiosis of obesity mutants in the age of leptin.

Authors:  Wenwen Zeng; Yi-Hsueh Lu; Jonah Lee; Jeffrey M Friedman
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-06       Impact factor: 11.205

4.  Leptin receptor activation of SH2 domain containing protein tyrosine phosphatase 2 modulates Ob receptor signal transduction.

Authors:  C Li; J M Friedman
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-17       Impact factor: 11.205

5.  Leptin Receptor Deficiency Results in Hyperphagia and Increased Fatty Acid Mobilization during Fasting in Rainbow Trout (Oncorhynchus mykiss).

Authors:  Jamie L Mankiewicz; Matthew J Picklo; Joseph Idso; Beth M Cleveland
Journal:  Biomolecules       Date:  2022-03-29

6.  Phenotypic effects of an induced mutation of the ObRa isoform of the leptin receptor.

Authors:  Zhiying Li; Giovanni Ceccarini; Michael Eisenstein; Keith Tan; Jeffrey Michael Friedman
Journal:  Mol Metab       Date:  2013-08-04       Impact factor: 7.422

7.  Metabolic characterization of a mouse deficient in all known leptin receptor isoforms.

Authors:  Olivia Osborn; Manuel Sanchez-Alavez; Sara E Brownell; Brendon Ross; Joe Klaus; Jeffrey Dubins; Bruce Beutler; Bruno Conti; Tamas Bartfai
Journal:  Cell Mol Neurobiol       Date:  2009-07-07       Impact factor: 5.046

Review 8.  Obesity and obstructive sleep apnea: pathogenic mechanisms and therapeutic approaches.

Authors:  Alan R Schwartz; Susheel P Patil; Alison M Laffan; Vsevolod Polotsky; Hartmut Schneider; Philip L Smith
Journal:  Proc Am Thorac Soc       Date:  2008-02-15

Review 9.  Leptin: pathogenesis and treatment of morbid obesity.

Authors:  A Kumar; N A Inverso; C D Still
Journal:  Curr Gastroenterol Rep       Date:  2000-08

10.  Reduced body weight and increased energy expenditure in transgenic mice over-expressing soluble leptin receptor.

Authors:  Phing-How Lou; Guoqing Yang; Lu Huang; Yunxia Cui; Tiffany Pourbahrami; George K Radda; Cai Li; Weiping Han
Journal:  PLoS One       Date:  2010-07-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.